跳至主要内容
临床试验/RPCEC00000315
RPCEC00000315招募中未知

Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study (COVID-19) - InmunoCorona

Finlay Vaccine Institute (IFV)0 个研究点目标入组 60 人开始时间: 2020年5月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Prevention

入排标准

年龄范围
60 years 至 one(—)
性别
All

入选标准

  • 1.- Female or male subject, age = 60 years.
  • 2.- Written consent to participate in the study.
  • 3.- Negative result to the rapid antibody test against COVID-19.

排除标准

  • 1.- Subject with a history of acute infectious disease at the time of application of the research products or in the 7 days prior to the administration of the same
  • 2.- Subject with a history of acute allergic processes or a history of severe allergic reactions.
  • 3.- Subject with a history of chronic decompensation diseases
  • 4.- Subjects with known hypersensitivity to any of the components of the research products
  • 5.- Subjects with immunomodulatory treatment (immunostimulatory or immunosuppressive)
  • 6.- Immunocompromised or immunosuppressed subjects (eg HIV, autoimmune disease)
  • 7.- Subjects who received the research products three months before the start of the research

研究者

发起方
Finlay Vaccine Institute (IFV)

相似试验